Chemaitelly, Hiam

Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design

Ayoub, H. H., Tomy, M., Chemaitelly, H., Altarawneh, H. N., Coyle, P., Tang, P., Hasan, M. R., Kanaani, Z. A., Kuwari, E. A., Butt, A. A., et al. (2022) · American Journal of Epidemiology

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 41

Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar

Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Tang, P., Hasan, M. R., Yassine, H. M., Khatib, H. A. A., Smatti, M. K., Coyle, P., Kanaani, Z. A., et al. (2022) · medRxiv

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 30

SARS-CoV-2 vaccine effectiveness in immunosuppressed kidney transplant recipients

Chemaitelly, H., AlMukdad, S., Joy, J. P., Ayoub, H. H., Yassine, H. M., Benslimane, F. M., Al Khatib, H. A., Tang, P., Hasan, M. R., Coyle, P., et al. (2021) · medRxiv

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 12